Racial/Ethnic variation in carotid artery revascularization utilization and outcomes: analysis from the National

Siddharth A Wayangankar1, Kevin F Kennedy1, Herbert D Aronow1

  • 1From the Cleveland Clinic Foundation, OH (S.A.W.); Mid America Heart and Vascular Institute, St. Luke's Hospital, Kansas City, MO (K.F.K.); Michigan Heart and Vascular Institute, Ypsilanti (H.D.A.); Holy Name Medical Center, Teaneck, NJ (J.R.); University of Oklahoma Health Sciences Center and Veterans' Affairs Medical Center (A.T., B.P., C.A.S., F.L.); and Massachusetts General Hospital, Boston (D.D.).

Stroke
|May 9, 2015
PubMed

Insights

Racial disparities exist in carotid revascularization. While in-hospital events were similar, Black patients undergoing carotid artery stenting (CAS) or endarterectomy (CEA) had higher 30-day adverse events, indicating disparities in care.

Area of Science:

  • Vascular Surgery
  • Health Disparities
  • Cardiovascular Outcomes

Background:

  • Racial and ethnic disparities are documented in various revascularization procedures.
  • It remains unclear if these disparities extend to carotid artery stenting (CAS) and carotid endarterectomy (CEA).

Purpose of the Study:

  • To investigate racial and ethnic disparities in the utilization and outcomes of CAS and CEA.
  • To compare procedure adoption and patient results across different racial/ethnic groups.

Main Methods:

  • Analysis of the CARE Registry data from May 2007 to December 2012.
  • Comparison of CAS and CEA utilization and outcomes stratified by race/ethnicity.
  • Risk adjustment for 30-day outcomes.

Main Results:

  • Non-Hispanic whites comprised the majority of patients undergoing both CAS (89.3%) and CEA (92.6%).
  • CAS utilization increased among non-Hispanic whites and other groups, while CEA utilization increased among Hispanics and blacks.
  • In-hospital adverse events were comparable; however, Black patients experienced higher 30-day stroke and major adverse cardiac and cerebrovascular events after CEA.

Conclusions:

  • Significant racial/ethnic differences were observed in the utilization trends of CAS and CEA.
  • While in-hospital outcomes were similar, Black patients faced higher 30-day adverse events post-CEA, suggesting persistent disparities.
Abstract

Related Concept Videos